SEC Form 4 · accession 0001288123-16-000078
AGENUS INC · AGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ozer Baysal
Officer — Chief Business Officer
Period of report
Jun 14, 2016
Accepted (ET)
Jun 16, 2016 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001098972
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| stock Option, right to buyF1 | $4.16 | Jun 14, 2016 | A | 40,000 | A | Mar 31, 2017 | Mar 31, 2026 | Common Stock | 40,000 | 40,000 | D |
| Restricted Stock UnitF2 | — | Jun 14, 2016 | A | 13,500 | A | Mar 31, 2019 | Mar 31, 2019 | Common Stock | 13,500 | 13,500 | D |
Explanation of responses
- F1Option was granted on March 31, 2016 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 14, 2016. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan, and vests over three years with one-third of the award vesting on March 31, 2017 and the balance vesting in equal quarterly installments thereafter.
- F2Award was granted on March 31, 2016 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 14, 2016. RSU awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, and is eligible to vest in a single installment on March 31, 2019 based upon Company stock price performance. Amount shown reflects the target award. The ultimate award size can range between 50% and 150% of the target based on the actual average stock price achieved.